GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (NAS:BOLT) » Definitions » Days Sales Outstanding

BioLight Life Sciences (BioLight Life Sciences) Days Sales Outstanding : 1,053.52 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is BioLight Life Sciences Days Sales Outstanding?

BioLight Life Sciences's average Accounts Receivable for the six months ended in Dec. 2023 was $0.13 Mil. BioLight Life Sciences's Revenue for the six months ended in Dec. 2023 was $0.02 Mil. Hence, BioLight Life Sciences's Days Sales Outstanding for the six months ended in Dec. 2023 was 1,053.52.

The historical rank and industry rank for BioLight Life Sciences's Days Sales Outstanding or its related term are showing as below:

BOLT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 8.89   Med: 140.61   Max: 2311.67
Current: 1412.57

During the past 12 years, BioLight Life Sciences's highest Days Sales Outstanding was 2311.67. The lowest was 8.89. And the median was 140.61.

BOLT's Days Sales Outstanding is ranked worse than
97.19% of 889 companies
in the Biotechnology industry
Industry Median: 71.03 vs BOLT: 1412.57

BioLight Life Sciences's Days Sales Outstanding declined from Dec. 2022 (1,539.08) to Dec. 2023 (1,053.52).


BioLight Life Sciences Days Sales Outstanding Historical Data

The historical data trend for BioLight Life Sciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences Days Sales Outstanding Chart

BioLight Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 45.63 - 2,372.50 1,248.06

BioLight Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 13,596.25 1,539.08 2,534.72 1,053.52

Competitive Comparison of BioLight Life Sciences's Days Sales Outstanding

For the Biotechnology subindustry, BioLight Life Sciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLight Life Sciences's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLight Life Sciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BioLight Life Sciences's Days Sales Outstanding falls into.



BioLight Life Sciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BioLight Life Sciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.104 + 0.108) / 2 ) / 0.031*365
=0.106 / 0.031*365
=1,248.06

BioLight Life Sciences's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.146 + 0.108) / 2 ) / 0.022*365 / 2
=0.127 / 0.022*365 / 2
=1,053.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLight Life Sciences  (NAS:BOLT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


BioLight Life Sciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLight Life Sciences (BioLight Life Sciences) Business Description

Traded in Other Exchanges
Address
Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101
BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.

BioLight Life Sciences (BioLight Life Sciences) Headlines